BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28566721)

  • 1. A novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) specifically detects CXCR4 expressing tumors.
    Santagata S; Portella L; Napolitano M; Greco A; D'Alterio C; Barone MV; Luciano A; Gramanzini M; Auletta L; Arra C; Zannetti A; Scala S
    Sci Rep; 2017 May; 7(1):2554. PubMed ID: 28566721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1.
    D'Alterio C; Buoncervello M; Ieranò C; Napolitano M; Portella L; Rea G; Barbieri A; Luciano A; Scognamiglio G; Tatangelo F; Anniciello AM; Monaco M; Cavalcanti E; Maiolino P; Romagnoli G; Arra C; Botti G; Gabriele L; Scala S
    J Exp Clin Cancer Res; 2019 Oct; 38(1):432. PubMed ID: 31661001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL12 loaded-dermal filler captures CXCR4 expressing melanoma circulating tumor cells.
    Ieranò C; D'Alterio C; Giarra S; Napolitano M; Rea G; Portella L; Santagata A; Trotta AM; Barbieri A; Campani V; Luciano A; Arra C; Anniciello AM; Botti G; Mayol L; De Rosa G; Pacelli R; Scala S
    Cell Death Dis; 2019 Jul; 10(8):562. PubMed ID: 31332163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells.
    Murakami T; Maki W; Cardones AR; Fang H; Tun Kyi A; Nestle FO; Hwang ST
    Cancer Res; 2002 Dec; 62(24):7328-34. PubMed ID: 12499276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical development of a novel class of CXCR4 antagonist impairing solid tumors growth and metastases.
    Portella L; Vitale R; De Luca S; D'Alterio C; Ieranò C; Napolitano M; Riccio A; Polimeno MN; Monfregola L; Barbieri A; Luciano A; Ciarmiello A; Arra C; Castello G; Amodeo P; Scala S
    PLoS One; 2013; 8(9):e74548. PubMed ID: 24058588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR4-targeted near-infrared imaging allows detection of orthotopic and metastatic human osteosarcoma in a mouse model.
    Guan G; Lu Y; Zhu X; Liu L; Chen J; Ma Q; Zhang Y; Wen Y; Yang L; Liu T; Wang W; Ran H; Qiu X; Ke S; Zhou Y
    Sci Rep; 2015 Oct; 5():15244. PubMed ID: 26472699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and characterization of a melanoma-targeted fluorescence imaging probe by conjugation of a melanocortin 1 receptor (MC1R) specific ligand.
    Tafreshi NK; Huang X; Moberg VE; Barkey NM; Sondak VK; Tian H; Morse DL; Vagner J
    Bioconjug Chem; 2012 Dec; 23(12):2451-9. PubMed ID: 23116461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the CXCR4 chemokine receptor enhances biological functions associated with B16 melanoma liver metastasis.
    Mendt M; Cardier JE
    Melanoma Res; 2017 Aug; 27(4):300-308. PubMed ID: 28445180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fast clearing RGD-based near-infrared fluorescent probes for in vivo tumor diagnosis.
    Cao J; Wan S; Tian J; Li S; Deng D; Qian Z; Gu Y
    Contrast Media Mol Imaging; 2012; 7(4):390-402. PubMed ID: 22649045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
    Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
    Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, characterization and optimization of in vitro properties of NIR-fluorescent cyclic α-MSH peptides for melanoma imaging.
    von Kiedrowski V; Hübner R; Kail D; Cheng X; Schirrmacher R; Wängler C; Wängler B
    J Mater Chem B; 2020 Dec; 8(46):10602-10608. PubMed ID: 33136101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of chemokine receptor CXCR4 gene by RNA interference: Effects on the B16-F10 melanoma growth.
    André ND; Silva VA; Watanabe MA; De Lucca FL
    Oncol Rep; 2016 Apr; 35(4):2419-24. PubMed ID: 26883290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of a
    Mikaeili A; Erfani M; Sabzevari O
    Nucl Med Biol; 2017 Nov; 54():10-17. PubMed ID: 28810154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delta-Opioid Receptor (δOR) Targeted Near-Infrared Fluorescent Agent for Imaging of Lung Cancer: Synthesis and Evaluation In Vitro and In Vivo.
    Cohen AS; Patek R; Enkemann SA; Johnson JO; Chen T; Toloza E; Vagner J; Morse DL
    Bioconjug Chem; 2016 Feb; 27(2):427-38. PubMed ID: 26488422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells.
    Su L; Zhang J; Xu H; Wang Y; Chu Y; Liu R; Xiong S
    Clin Cancer Res; 2005 Dec; 11(23):8273-80. PubMed ID: 16322285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR4-antagonist Peptide R-liposomes for combined therapy against lung metastasis.
    Ieranò C; Portella L; Lusa S; Salzano G; D'Alterio C; Napolitano M; Buoncervello M; Macchia D; Spada M; Barbieri A; Luciano A; Barone MV; Gabriele L; Caraglia M; Arra C; De Rosa G; Scala S
    Nanoscale; 2016 Apr; 8(14):7562-71. PubMed ID: 26983756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a Carbonic Anhydrase IX-Targeted Near-Infrared Dye for Fluorescence-Guided Surgery of Hypoxic Tumors.
    Lv PC; Roy J; Putt KS; Low PS
    Mol Pharm; 2016 May; 13(5):1618-25. PubMed ID: 27043317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Near-infrared optical imaging of B16 melanoma cells via low-density lipoprotein-mediated uptake and delivery of high emission dipole strength tris[(porphinato)zinc(II)] fluorophores.
    Wu SP; Lee I; Ghoroghchian PP; Frail PR; Zheng G; Glickson JD; Therien MJ
    Bioconjug Chem; 2005; 16(3):542-50. PubMed ID: 15898720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via beta(1) integrin.
    Cardones AR; Murakami T; Hwang ST
    Cancer Res; 2003 Oct; 63(20):6751-7. PubMed ID: 14583470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo knockdown of CXCR4 using jetPEI/CXCR4 shRNA nanoparticles inhibits the pulmonary metastatic potential of B16‑F10 melanoma cells.
    André ND; Silva VA; Ariza CB; Watanabe MA; De Lucca FL
    Mol Med Rep; 2015 Dec; 12(6):8320-6. PubMed ID: 26498029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.